MedLife, afaceri în creștere în primul semestru, susținute de tranzacțiile finalizate în 2025 și 2026

MedLife reported a consolidated pro forma revenue of 1.7 billion RON in the first half of 2026, marking a 10% increase from the same period in 2025. The growth was driven by all business lines and recent acquisitions. EBITDA margin improved to 16.4%, with significant increases in corporate, clinic, and laboratory divisions. CEO Mihai Marcu emphasized ongoing strategic projects focused on innovation and digitalization, despite a challenging macroeconomic environment. Financial losses rose due to currency depreciation, impacting net results.